Atlas Trials

Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Clinical trial NCT00004139 · COMPLETED

Trial details

NCT number
NCT00004139
Sponsor
Alliance for Clinical Trials in Oncology
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Cancer
Start date
1999-09-01
Primary completion
2004-07-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.